- Home
- PRPO vs SOAR Comparison
PRPO vs SOAR Comparison
Compare PRPO & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- SOAR
- Stock Information
- Founded
- PRPO N/A
- SOAR 2021
- Country
- PRPO United States
- SOAR United States
- Employees
- PRPO N/A
- SOAR N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- SOAR Blank Checks
- Sector
- PRPO Industrials
- SOAR Finance
- Exchange
- PRPO Nasdaq
- SOAR Nasdaq
- Market Cap
- PRPO 8.8M
- SOAR 9.3M
- IPO Year
- PRPO N/A
- SOAR N/A
- Fundamental
- Price
- PRPO $6.51
- SOAR $0.21
- Analyst Decision
- PRPO
- SOAR
- Analyst Count
- PRPO 0
- SOAR 0
- Target Price
- PRPO N/A
- SOAR N/A
- AVG Volume (30 Days)
- PRPO 8.3K
- SOAR 2.9M
- Earning Date
- PRPO 11-06-2024
- SOAR 11-18-2024
- Dividend Yield
- PRPO N/A
- SOAR N/A
- EPS Growth
- PRPO N/A
- SOAR N/A
- EPS
- PRPO N/A
- SOAR N/A
- Revenue
- PRPO $17,411,000.00
- SOAR $102,271,000.00
- Revenue This Year
- PRPO $75.18
- SOAR N/A
- Revenue Next Year
- PRPO N/A
- SOAR N/A
- P/E Ratio
- PRPO N/A
- SOAR N/A
- Revenue Growth
- PRPO 31.31
- SOAR 97.25
- 52 Week Low
- PRPO $4.31
- SOAR $0.17
- 52 Week High
- PRPO $7.30
- SOAR $4.50
- Technical
- Relative Strength Index (RSI)
- PRPO 64.52
- SOAR 42.74
- Support Level
- PRPO $6.00
- SOAR $0.19
- Resistance Level
- PRPO $6.34
- SOAR $0.29
- Average True Range (ATR)
- PRPO 0.37
- SOAR 0.03
- MACD
- PRPO 0.09
- SOAR -0.00
- Stochastic Oscillator
- PRPO 100.00
- SOAR 21.08
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About SOAR Volato Group Inc.
Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.